insider24.ch
Holding / family officeRegistered location :Pratteln

Santhera Pharmaceuticals Holding AGDeclared Swiss shareholdings

Santhera Pharmaceuticals Holding AG: 1 Swiss companies with a declared holding, including Santhera Pharmaceuticals Holding AG. Latest filing: 15.01.2026.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
1
Largest position
40,17 %
Santhera Pharmaceuticals Holding AG
12-month trend
Net reducer
0 rate rises · 1 rate falls
Latest filing
15.01.2026
Active since 2017

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held

Santhera Pharmaceuticals Holding AG

40,17 %15.01.2026
How to read these figures?

Rates come from the 59 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure4 controls

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 0

90 days · Downward crossings

0

visible history: 52

First disclosure: 17.02.2017Last disclosure: 15.01.2026

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
52
Sale positions
661

Latest shareholding disclosures

SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

40.166%Voting rights sold15.01.2026
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

41.038%Voting rights sold14.01.2026
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

45.089%Voting rights sold30.09.2025
Show 37 older disclosures
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

30.633%Voting rights sold17.08.2024
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

39.484%Voting rights sold27.06.2024
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

39.76%Voting rights sold03.08.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

75.87%Voting rights sold26.07.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

73.74%Voting rights sold05.07.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

72.83%Voting rights sold29.06.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

72.83%Voting rights sold24.06.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

97.06%Voting rights sold07.03.2023
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

55%Voting rights sold18.03.2022
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

69.65%Voting rights sold17.03.2022
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

77.02%Voting rights sold01.10.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

52.27%Voting rights sold07.09.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

67.54%Voting rights sold24.08.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

66.07%Voting rights sold07.08.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

60.67%Voting rights sold08.06.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

78.23%Voting rights sold28.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

77.54%Voting rights sold27.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

84.3%Voting rights sold18.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

91.7%Voting rights sold11.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

87.91%Voting rights sold07.05.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

97.72%Voting rights sold29.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

94.17%Voting rights sold24.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

40.01%Voting rights sold14.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

49.57%Voting rights sold09.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

52.54%Voting rights sold07.04.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

56.99%Voting rights sold26.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

58.49%Voting rights sold17.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

60.92%Voting rights sold06.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

61.51%Voting rights sold04.03.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

51.68%Voting rights sold23.02.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

43.21%Voting rights sold11.02.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

53.28%Voting rights sold21.01.2021
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

59.61%Voting rights sold02.12.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

85.05%Voting rights sold07.11.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

71.8%Voting rights sold29.10.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

58.42%Voting rights sold19.09.2020
SaleShareholdings

Santhera Pharmaceuticals Holding AG

Santhera Pharmaceuticals Holding AG · Single shareholder

63.42%Voting rights sold21.07.2020

insider24.ch

Follow Santhera Pharmaceuticals Holding AG’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in Santhera Pharmaceuticals Holding AG’s disclosed portfolio?

    Santhera Pharmaceuticals Holding AG.

    What is Santhera Pharmaceuticals Holding AG’s latest disclosure?

    The latest available disclosure was published on 15.01.2026 and concerns Santhera Pharmaceuticals Holding AG. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.